Wang Wei, DU Yan, Lin Guo-Qiang, Li Nan-Nan, Sun Bing-Zhong
Department of Hematology, PLA 175th Hospitol, Zhangzhou 363000, Fujian Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Jun;18(3):606-11.
This study was purposed to explore the effect of specific small interfering RNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on the proliferation, cell cycle and apoptosis of chronic myeloid leukemia (CML) cell line K562. CML cell line K562 was used as the study object. A 21nt siRNA targeting at the fusion site of b3:a2 mRNA in bcr-abl fusion gene was designed, synthesized and transfected into the K562 cells as RNA interference group. Northern blot was used to detect the bcr-abl fusion gene, Western blot was used to detect the expression of P210 protein and apoptosis-related protein BCL-xL after the transfection. Meanwhile, p27 gene was amplified from peripheral blood mononuclear cells by RT-PCR, and was confirmed to be correct by sequencing, then p27-pcDNA3.1 vector was constructed and transfected into K562 cell line by Lipofectin. After being selected with G418, p27-pcDNA3.1-K562 cell clone stably expressing p27 was isolated. P27 protein was identified by Western blot. Finally, siRNA and p27 gene clone were together applied to K562 cells, the cell survival rate was tested by MTT. The cell cycle and the apoptosis were tested by flow cytometry. The result showed that in contrast with the control group, the expression level of bcr-abl fusion gene was much lower in siRNA group, about 18.4% of K562 cells in siRNA group were apoptotic at 24 hours after siRNA transfection, and the expression of apoptosis-associated protein BCL-xL was greatly down-regulated. The expression of P27 protein could be detected by Western blot in p27-pcDNA3.1-K562 cells. The strong inhibition of cell proliferation was observed in p27-pcDNA3.1-K562 cells, as compared with control K562 cells. The count of p27-pcDNA3.1-K562 cells in G(0)/G(1) phase increased apparently, but that in S phase declined greatly. Cell cycle was arrested in G(0)/G(1) phase. After the combination of p27-pcDNA3.1-K562 cells with specific siRNA, the percentage of apoptosis obviously increased and cell survival rate significantly declined. It is concluded that the specific siRNA distinctly inhibits the expression of bcr-abl fusion gene, and can induce K562 cell apoptosis. The combination of specific siRNA with P27 gene clone displays a synergy of inhibition and pro-apoptosis effects to K562 cells.
本研究旨在探讨靶向bcr-abl融合基因的特异性小干扰RNA及其与p27基因克隆联合应用对慢性髓性白血病(CML)细胞系K562增殖、细胞周期及凋亡的影响。以CML细胞系K562为研究对象。设计、合成了针对bcr-abl融合基因中b3:a2 mRNA融合位点的21nt siRNA,并将其转染至K562细胞作为RNA干扰组。转染后采用Northern印迹法检测bcr-abl融合基因,采用Western印迹法检测P210蛋白及凋亡相关蛋白BCL-xL的表达。同时,通过RT-PCR从外周血单个核细胞中扩增p27基因,测序鉴定正确后构建p27-pcDNA3.1载体,并用Lipofectin转染至K562细胞系。经G418筛选后,分离出稳定表达p27的p27-pcDNA3.1-K562细胞克隆。通过Western印迹法鉴定P27蛋白。最后,将siRNA与p27基因克隆联合应用于K562细胞,采用MTT法检测细胞存活率。通过流式细胞术检测细胞周期及凋亡情况。结果显示,与对照组相比,siRNA组bcr-abl融合基因表达水平明显降低,siRNA转染后24小时,siRNA组约18.4%的K562细胞发生凋亡,凋亡相关蛋白BCL-xL表达明显下调。在p27-pcDNA3.1-K562细胞中可通过Western印迹法检测到P27蛋白表达。与对照K562细胞相比,p27-pcDNA3.1-K562细胞对细胞增殖有较强抑制作用。p27-pcDNA3.1-K562细胞G(0)/G(1)期细胞计数明显增加,而S期细胞计数明显减少。细胞周期阻滞于G(0)/G(1)期。p27-pcDNA3.1-K562细胞与特异性siRNA联合应用后,凋亡率明显增加,细胞存活率明显下降。结论:特异性siRNA可明显抑制bcr-abl融合基因表达,并可诱导K562细胞凋亡。特异性siRNA与P27基因克隆联合应用对K562细胞具有抑制和促凋亡的协同作用。